AI Article Synopsis
- Hyperprolactinemia is a frequent cause of secondary amenorrhea, found in 20-25% of cases, and was observed in a 40-year-old patient with spaniomenorrhea and inguinal pain.
- After ruling out other causes, it was concluded that the patient's moderate hyperprolactinemia was linked to alprazolam use, a benzodiazepine.
- The article highlights the underrecognized potential of benzodiazepines to cause hyperprolactinemia, urging awareness among healthcare providers, especially since the use of these medications is prevalent in France.
Article Abstract
Hyperprolactinemia is common and accounts for 20 to 25% of secondary amenorrhea causes. Here, we report a case of moderate hyperprolactinemia observed in a 40-year-old patient consulting for spaniomenorrhea and inguinal pain during a bartholinitis episode. After eliminating all known causes of hyperprolactinemia, alprazolam intake is finally assumed. This hyperprolactinemia is found in a few bibliographic studies and is also noted in the summary of product characteristics. However, benzodiazepines are not known as hyperprolactinemia-inducing drugs by the endocrinologists and do not appear in the list of drugs established by a consensus of experts from the French Society of Endocrinology. This article aims to increase awareness of prescribing physicians and biologists of the possible occurrence of hyperprolactinemia in patients treated by benzodiazepines, especially since the intake of this molecule is particularly common in France, whether it is a medical prescription or self-medication.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1684/abc.2020.1565 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!